|
|
CDC NIP/NIC Home Page
|
Count Basie B
| |||
C2: Vaccine-Preventable Disease Surveillance | |||
| The goals and priority areas for vaccine-preventable disease surveillance in the United States will be discussed, as well as strategies for enhancing and evaluating surveillance. The current needs for HPV surveillance will be discussed in the context of this very new vaccination program. | |||
| Moderator: | Sandra Roush | ||
| 3:30 PM | Introductory Remarks | ||
| 3:35 PM | 17 | Surveillance for Vaccine-Preventable Diseases (VPDs) Sandra W. Roush | |
| 3:43 PM | 18 | Assessing the Quality of National Vaccine-Preventable Disease (VPD) Surveillance Using Surveillance Indicators Sandra W. Roush | |
| 3:50 PM | Using Vaccine-Preventable Disease Surveillance Indicators for Evaluation Denise Woods-Stout | ||
| 4:05 PM | Human Papillomavirus: Do We Need Surveillance Now? Deblina Datta | ||
| 4:20 PM | Discussion | ||